These findings were recently extended to lung cancer in a gene set enrichment analysis of RNA-seq data, demonstrating upregulation of genes in the inflammation and complement pathway, besides upregulation of genes associated with the KRAS signaling pathway [12]. This evidence concerns the gene KRAS and lung cancer.